JAZZ FY 2012 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$586M+115.2% YoY

Gross Profit

$508M86.6% margin

Operating Income

$198M33.8% margin

Net Income

$289M49.2% margin

EPS (Diluted)

$4.79

Cash Flow

Operating Cash Flow

$250M

Free Cash Flow

$227M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$845M

Stockholders' Equity

$1.1B

Cash & Equivalents

$387M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$586M	$272M	+115.2%
Gross Profit	$508M	$258M	+96.5%
Operating Income	$198M	$128M	+54.8%
Net Income	$289M	$125M	+130.9%